Ritholtz Wealth Management Acquires 9,293 Shares of Utah Medical Products, Inc. $UTMD

Ritholtz Wealth Management lifted its holdings in Utah Medical Products, Inc. (NASDAQ:UTMD) by 168.5% in the 1st quarter, Holdings Channel reports. The firm owned 14,807 shares of the medical instruments supplier’s stock after acquiring an additional 9,293 shares during the period. Ritholtz Wealth Management’s holdings in Utah Medical Products were worth $918,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also recently modified their holdings of the business. Brandes Investment Partners LP boosted its position in shares of Utah Medical Products by 4.0% during the fourth quarter. Brandes Investment Partners LP now owns 351,322 shares of the medical instruments supplier’s stock valued at $19,660,000 after buying an additional 13,392 shares during the last quarter. Segall Bryant & Hamill LLC purchased a new position in Utah Medical Products in the 3rd quarter worth about $726,000. Quantinno Capital Management LP purchased a new position in Utah Medical Products in the 2nd quarter worth about $608,000. Geode Capital Management LLC lifted its stake in Utah Medical Products by 6.5% during the 2nd quarter. Geode Capital Management LLC now owns 114,816 shares of the medical instruments supplier’s stock valued at $6,537,000 after acquiring an additional 7,040 shares during the period. Finally, Goldman Sachs Group Inc. lifted its stake in Utah Medical Products by 114.9% during the 4th quarter. Goldman Sachs Group Inc. now owns 11,033 shares of the medical instruments supplier’s stock valued at $617,000 after acquiring an additional 5,900 shares during the period. 69.60% of the stock is owned by institutional investors.

Wall Street Analyst Weigh In

Separately, Weiss Ratings reiterated a “hold (c-)” rating on shares of Utah Medical Products in a research note on Friday, May 22nd. One research analyst has rated the stock with a Hold rating, Based on data from MarketBeat.com, the stock presently has an average rating of “Hold”.

Utah Medical Products Price Performance

NASDAQ UTMD opened at $73.97 on Monday. The stock’s 50-day moving average price is $66.56 and its 200-day moving average price is $63.63. Utah Medical Products, Inc. has a 52 week low of $53.66 and a 52 week high of $75.75. The company has a market capitalization of $235.22 million, a P/E ratio of 21.88 and a beta of 0.37.

Utah Medical Products (NASDAQ:UTMD) last announced its quarterly earnings data on Thursday, April 23rd. The medical instruments supplier reported $0.82 earnings per share (EPS) for the quarter. The company had revenue of $8.72 million during the quarter. Utah Medical Products had a return on equity of 9.13% and a net margin of 28.90%.

Utah Medical Products Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Friday, July 3rd. Shareholders of record on Wednesday, June 17th will be issued a dividend of $0.31 per share. The ex-dividend date of this dividend is Wednesday, June 17th. This represents a $1.24 annualized dividend and a yield of 1.7%. Utah Medical Products’s payout ratio is currently 36.69%.

Utah Medical Products Company Profile

Utah Medical Products, Inc (NASDAQ: UTMD), headquartered in Midvale, Utah, is a designer, manufacturer and marketer of single‐use medical devices focusing principally on respiratory therapy and patient monitoring applications. Since its founding in the late 1970s, the company has built a reputation for innovation in airway management and non‐invasive monitoring products used in acute and long‐term care settings.

The company’s core product portfolio includes tracheostomy tubes and related accessories, endotracheal tube holders, disposable catheters and sensors for measuring end‐tidal carbon dioxide (CO₂).